A consortium of 20 major banks has just written an $18 billion check—no, that’s not a misprint—to help underwrite Oracle’s (ORCL) latest ambition: a sprawling data center campus in New Mexico that promises to give even the most jaded AI skeptic a…
JFrog’s (FROG) third-quarter 2025 performance was anything but amphibious—unless “leaping” counts. The company vaulted past Wall Street forecasts, croaking out revenue of $139.6 million, soaring 26% year-over-year and leaving analysts' modest predictions somewhere in the lily pads. Investors had reason to rejoice;…
Tesla (TSLA) shareholders have given a resounding nod to CEO Elon Musk’s audacious $1 trillion pay package, a deal so outsized it makes the GDPs of small nations seem quaint by comparison. Approved by more than 75% of voters at the company’s…
Wall Street ended Thursday, November 6, 2025, sharply lower as surging volatility and renewed skepticism over tech valuations sent both large and small caps reeling. The Dow Jones Industrial Average finished down 0.84% at 46,912.30, the S&P 500 lost 1.1% to close…
Apple (AAPL) is setting the stage for a future that might make even Siri do a double-take: by 2040, analysts at Morgan Stanley (MS) predict Apple could rake in an astonishing $133 billion a year from humanoid robotics, a number robust enough…
This week, the pharmaceutical world witnessed a seismic shift as Eli Lilly (LLY) and Novo Nordisk (NVO) entered the headlines with deals to make their coveted obesity medications far more affordable for Americans. Responding to the administration’s call to rein in soaring…
Solid Power’s (SLDP, $8.51, Up +350.26% YTD) third-quarter story reads a bit like an Arthur Miller play staged in Silicon Valley: heady ambitions, strategic names stepping onto the set, and the comforting aroma of liquidity—punctuated by the occasional plot twist in quarterly…
Wall Street ushered in Wednesday, November 5, 2025 with a refreshed dose of optimism—and just a dash of sophisticated exasperation—as major indices snapped back from recent turbulence driven by AI sector jitters and global macroeconomic suspense. The S&P 500 closed at 6,796.29,…
Eupraxia Pharmaceuticals (EPRX) delivered an impressive third quarter for 2025, underpinned by breakthrough clinical data, robust financial positioning, and a clearer trajectory toward commercial success. The company’s RESOLVE trial in eosinophilic esophagitis (EoE) demonstrated sustained clinical remission and long-lasting improvements in tissue…
McDonald's has proven that nostalgia can be a lucrative business strategy, as the prodigal Snack Wrap has returned to its American menu after a nine-year hiatus—and promptly delivered a performance worth clucking about. In the fast-paced world of fast food, nothing gets…